Big pharma, Financing, Pharma

Warner Chilcott in $4.4 billion loan financing and debt financing

Posted on 09 July 2013

Tags: , , ,

Warner Chilcott is in market with $4.4 billion in loan financing and debt financing following the company's acquisition by drug manufacturer Actavis.

The big pharma company is looking to raise $2 billion in new term loan financing.

Warner Chilcott is also looking to amend and extend $2.4 billion of existing senior secured credit facilities at the Actavis level.

Proceeds from the two new term loans and $425 million in cash will repay $2.45 billion of existing Warner Chilcott bank debt financing.

The amended loans, meanwhile, will replace a $1.8 billion term loan Actavis entered in June 2012 and a $750 million revolver from September 2011.

Bank of America Merrill Lynch and JP Morgan are joint bookrunners for the debt financing round.

BAML, JP Morgan HSBC, Bank of Tokyo-Mitsubishi and Mizuho are joint lead arrangers for the debt financing round.

The new facilities consist of a $1 billion, three-year term loan and a $1 billion, five-year term loan.

The amended facilities consist of a $1.65 billion, four year term loan and a $750 million revolver.

Related

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Report: Partnering Deals and Alliances with Warner Chilcott

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply